Circumvention of P-gp and MRP2 mediated efflux of lopinavir by a histidine based dipeptide prodrug
Authors:
- 1 October 2016
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 512 (1) , 49-60
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01AI071199)
This publication has 25 references indexed in Scilit:
- Design of Lipophilic Prodrugs to Improve Drug Delivery and EfficacyCurrent Drug Targets, 2016
- Expression of the peptide transporters PepT1, PepT2, and PHT1 in the embryonic and posthatch chickPoultry Science, 2013
- Influence of overexpression of efflux proteins on the function and gene expression of endogenous peptide transporters in MDR-transfected MDCKII cell linesInternational Journal of Pharmaceutics, 2013
- Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.2011
- Prodrugs for improving tumor targetability and efficiencyAdvanced Drug Delivery Reviews, 2011
- Lopinavir/ritonavir in the treatment of HIV-1 infection: a reviewTherapeutics and Clinical Risk Management, 2008
- Transport Proteins and Intestinal MetabolismTherapeutic Drug Monitoring, 2004
- Lopinavir/RitonavirDrugs, 2003
- Spatial expression patterns of peptide transporters in the human and rat gastrointestinal tracts, Caco-2 In Vitro cell culture model, and multiple human tissuesAAPS PharmSci, 2001
- Cyclosporin a used to reverse drug resistance increases vincristine neurotoxicityAmerican Journal of Hematology, 1992